Gaskin G and Pusey CD
Prevention of relapses in systemic vasculitis
Am Soc Nephrol
J Am Soc Nephrol (abstract)
(Nov) 6:921 1995
Relapse of ANCA + vasculitis occurs in up to 50% of patients and is 4 times
more likely in patients with Pr3-ANCA than in those with MPO-ANCA. Patients
with persistent ANCA were generally maintained on azathioprine/prednisone
whereas immunosuppressives were generally discontinued in those who became
ANCA negative. Low-dose maintenance therapy appears advisable in Pr3-ANCA
associated vasculitis.
(Leehey)
To go back use the BACK button on your browser.
Otherwise click on the desired link to this article below:
Am Soc Nephrol
Proteinuria/Hematuria :
Vasculitis (Wegener's PAN, etc.)